Targeted Cancer Therapy / Edition 1

Targeted Cancer Therapy / Edition 1

by Razelle Kurzrock
     
 

In the era of personalized medicine, cancer treatment has become a model for the use of targeted therapeutics. Leaving behind the "one size fits all" approach to cancer care, this book provides the practicing oncologist with an overview of the advances in treatment and an understanding of the implementation of new therapeutic agents. Targeted Cancer Therapy is

See more details below

Overview

In the era of personalized medicine, cancer treatment has become a model for the use of targeted therapeutics. Leaving behind the "one size fits all" approach to cancer care, this book provides the practicing oncologist with an overview of the advances in treatment and an understanding of the implementation of new therapeutic agents. Targeted Cancer Therapy is divided into twenty chapters covering specific hematologic malignancies and solid tumors, targeted and functional imaging, and combination therapies. Each disease specific chapter includes up-to-date information on investigational and FDA approved therapies which will enhance the reader’s ability to prescribe effective drug regimens. This includes combinations of therapies and therapeutic modalities to overcome drug resistance.

In a rapidly changing field, this book will enable clinicians to improve their ability to practice personalized health planning, make early diagnoses, and select optimal drugs for each patient with predictable side effects and outcomes. Poised to change the landscape in oncology, Targeted Cancer Therapy is essential for practicing and academic physicians, fellows, and residents.

Read More

Product Details

ISBN-13:
9781607615989
Publisher:
Springer-Verlag New York, LLC
Publication date:
12/09/2009
Series:
Current Clinical Oncology Series
Edition description:
2008
Pages:
446
Product dimensions:
6.70(w) x 9.60(h) x 1.10(d)

Meet the Author

Table of Contents

Chapter 1 Perspectives: Bench to Bedside and Back
Jennifer Wheler, MD and Razelle Kurzrock, MD, FACP

Chapter 2 Targeted Therapy in Acute Myelogenous Leukemia
Elihu Estey, MD

Chapter 3 Targeted Therapy in Breast Cancer
Barbara S. Craft, MD; Stacy Moulder, MD, MSCI

Chapter 4 Targeted Therapy in Chronic Lymphocytic Leukemia
Apostolia-Maria Tsimberidou, MD, PhD; Michael J. Keating, MD

Chapter 5 Targeted Therapy in Chronic Myeloid Leukemia
Elias Jabbour, MD; Jorge Cortes MD, Hagop Kantarjian, MD

Chapter 6 Targeted Therapy in Colorectal Cancer
Scott Kopetz, MD

Chapter 7 Targeted Therapy in Non-small Cell Lung Cancer
David J. Stewart, MD, FRCPC

Chapter 8 Targeted Therapy in Lymphoma
Amanda Wedgwood, MSN; Anas Younes, MD

Chapter 9 Targeted Therapy in Melanoma
Michael Davies, MD, PhD; Sunil Patel, MD; Kevin B. Kim, MD

Chapter 10 Targeted Therapy in Multiple Myeloma
Yuhong Zhou, MD; Raymond Alexanian, MD; Michael Wang, MD

Chapter 11 Targeted Therapy in Myelodysplastic Syndrome
Alfonso Quintás-Cardama, MD; Hagop Kantarjian, MD;
Guillermo Garcia-Manero, MD; Jorge Cortes, MD

Chapter 12 Targeted Therapy in Epithelial Ovarian Cancer
Maurie Markman, MD

Chapter 13 Targeted Drug Therapy in Pancreatic Cancer
Don L. Gibbons, MD, PhD; Robert A. Wolff MD,
Gauri Varadhachary, MD

Chapter 14 Targeted Therapy in Prostate Cancer
Amado J. Zurita MD; John F. Ward, MD; Jeri Kim, MD

Chapter 15 Targeted Therapy in Renal Cell Carcinoma
Eric Jonasch, MD; Nizar Tannir, MD

Chapter 16 Targeted Therapy of Sarcoma
Joseph Ludwig, MD; Jonathan C. Trent , MD, PhD

Chapter 17 Targeted and Functional Imaging
Vikas Kundra, MD, PhD; Dawid Schellingerhout, MD;
Edward F. Jackson, PhD

Chapter 18 Combining Targeted Therapies
David Hong, MD; Lakshmi Chintala, MD

Chapter 19: Drug Development in Cancer Medicine:
Challenges for Targeted Approaches
Luis H. Camacho, MD, MPH

Chapter 20: Toward Personalized Therapy for Cancer
Sarah J. Welsh, PhD, Garth Powis, DPHIL

Read More

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >